Oncolytic polio/rhinovirus recombinant (PVSRIPO) against WHO grade IV malignant glioma (MG): Experience with retreatment of survivors from the phase I trial.
Year: 2019
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: Annick Desjardins, Matthias Gromeier, James Emmett Herndon, Dina Randazzo, Stevie Threatt, Eric S. Lipp, Elizabeth S. Miller, Jennifer Jackman, Dani P. Bolognesi, Allan H. Friedman, Henry S. Friedman, Frances McSherry, Katherine B. Peters, Margaret O Johnson, John H. Sampson, David M. Ashley, Darell D. Bigner
Institution: Duke Medical Center
Language: English
Subfield: Genetics
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W2947590646